Načítá se...
Neuroimaging Biomarkers for Early Drug Development in Schizophrenia
Given the relative inability of currently available antipsychotic treatments to adequately provide sustained recovery and improve quality of life for patients with schizophrenia, new treatment strategies are urgently needed. One way to improve the therapeutic development process may be an increased...
Uloženo v:
| Hlavní autor: | |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2013
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4026337/ https://ncbi.nlm.nih.gov/pubmed/24094513 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.biopsych.2013.08.025 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|